ChemoCentryx to Host Virtual R&D Day on April 14, 2021
Presenters:
Thomas J. Schall , Ph.D.,President and Chief Executive Officer ofChemoCentryx - Tausif (“Tosh”) Butt, Executive Vice President and Chief Operating Officer of
ChemoCentryx David Jayne , M.D., Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital inCambridge Peter A. Merkel , M.D., MPH, Chief of Rheumatology and Professor of Medicine and Epidemiology at theUniversity of Pennsylvania Glen Massie , Patient living with ANCA-associated vasculitis
Virtual R&D Day Information:
- Date:
Wednesday, April 14, 2021 - Time:
12:30pm –3:00pm ET - Live webcast link: https://wsw.com/webcast/cc/ccxi2/
Following completion of the live event, an archived webcast can be accessed through the Investors section of the Company’s website at www.ChemoCentryx.com, approximately two hours following the event. The archived webcast will remain available on the Company’s website for 60 days.
About
Contacts:
Executive Vice President,
Chief Financial and Administrative Officer
investor@chemocentryx.com
Media:
408.234.1279
media@chemocentryx.com
Investors:
212.213.0006
lroth@burnsmc.com
Source: ChemoCentryx, Inc.